Research sheds light on what causes severe inflammatory bowel disease.

Published Date: 26 Apr 2023

Researchers from Cedars-Sinai have discovered a genetic variation that raises the risk of perianal Crohn's disease, the most crippling form of the condition, in susceptible individuals.

Read Full News

Latest News

Daraxonrasib Combo Shows Promise in First-Line mPDAC

A phase 1/2 trial shows strong early efficacy for daraxonrasib plus chemotherapy as first-line treatment for patients with metastatic pancreatic cancer — but toxicity is a concern.

Volume Matters in Ablative Radiotherapy for PDAC

Can definitive radiotherapy targeting the full ‘triangle’ space improve local disease control in patients with inoperable pancreatic cancer?

Fecal Microbiota From Younger Self Forestalls Aging in Mice

Preclinical research suggests altering the gut microbiome could someday hinder some signs of aging in people.

Pancreatic Cancer Vaccine Still Shows Promise 6 Years Out

The novel personalized mRNA vaccine also demonstrates the potential for such vaccines in other solid tumor types.

Preservatives and Cancer: What's the Real Risk?

Patients are increasingly asking about "chemicals" in food. What can clinicians tell them about preservatives and cancer risk?

Drug-Resistant Shigella Surges in Adult Men

Most previous US outbreaks involved children infected with drug-susceptible strains.

Todays Updates

Which Risk Model Better Identifies High-Risk Smoldering MM?

A cohort study compares the distribution and progression risk among individuals classified as having high-risk smoldering multiple myeloma by the AQUILA trial inclusion criteria vs 2/20/20 risk model.

Todays Updates

Which Risk Model Better Identifies High-Risk Smoldering MM?

A cohort study compares the distribution and progression risk among individuals classified as having high-risk smoldering multiple myeloma by the AQUILA trial inclusion criteria vs 2/20/20 risk model.

Latest News

A phase 1/2 trial shows strong early efficacy for daraxonrasib plus chemotherapy as first-line treatment for patients with metastatic pancreatic cancer — but toxicity is a concern.

Can definitive radiotherapy targeting the full ‘triangle’ space improve local disease control in patients with inoperable pancreatic cancer?

Preclinical research suggests altering the gut microbiome could someday hinder some signs of aging in people.

The novel personalized mRNA vaccine also demonstrates the potential for such vaccines in other solid tumor types.

Patients are increasingly asking about "chemicals" in food. What can clinicians tell them about preservatives and cancer risk?

Most previous US outbreaks involved children infected with drug-susceptible strains.

News All Time

Vaccination Protects Young Men From HPV-Related Cancers

HPV-related cancers — including anal, penile, and oropharyngeal — are rare in people younger than 50, but new research suggests vaccinated boys could see cancer protection in their teens and 20s.

The Intersection Between Gut and Spine Health

Emerging research is showing more and more connection between the two.

IBD Flare Prediction Improved by Psychosocial Data

Predictive models that combine patient-reported psychosocial measures with clinical data perform well in forecasting flares in patients with inflammatory bowel disease.

Sacral Fracture Risk After Short-Course RT for Rectal Cancer

A recent retrospective analysis assesses the incidence and risk factors for sacral fractures among patients receiving short-course radiation therapy for rectal cancer.

Heavy Drinking Tied to Young-Onset Pancreatic Cancer

A nationwide Korean cohort study of more than 6.2 million young adults found an association between heavy alcohol use and pancreatic cancer risk before age 50.

How Gut Bacteria Could Trigger Memory Loss as We Age

Researchers found potential links between gut bacteria and memory loss, with gut-brain connections triggering loss of memory encoding in the hippocampus.

AstraZeneca's Liver Cancer Therapy Combo Slows Disease Progression in Late-stage Trial

AstraZeneca said on Thursday that a combination treatment with its cancer drug Imfinzi showed significant improvement in ⁠how long patients with a common liver cancer lived...

Symptom-Based H pylori Testing Does Not Prevent Cancer

Most gastric cancers found in people diagnosed with H pylori may already be present at diagnosis, and treatment of the infection may not provide short-term protection.

Evidence Suggest Fewer GLP-1 Doses Maintain Weight Loss

Doctors have started to personalize GLP-1 dosing with surprising outcomes.

Cholera Aid for African Countries Stalled by Iran Conflict

Emergency cholera medical supplies for several African countries have become stuck in a logistical quagmire caused by the Iran war, aid officials told ⁠Reuters, raising...

New GERD Score May Help Clinicians Spot Biggest Symptom

In patients with GERD, dominant symptom intensity is a simple patient-reported measure that identifies the most burdensome symptom and tracks treatment response.

Can a Machine Learning Model Predict Liver Cancer?

Using routine clinical data, the model gauges liver cancer risk better than existing tools, offering a potential way to identify high-risk patients missed by current screening criteria.

IUS May Guide Treatment in Children With Ulcerative Colitis

Intestinal ultrasound scan may serve as an early non-invasive predictor of corticosteroid resistance and short-term colectomy in children with acute severe ulcerative colitis.

Routine EHR Data May Help Predict Pancreatic Cancer Risk

A risk model that uses routine clinical data can identify people at high risk of developing pancreatic cancer over the next 3 years.

Can Romiplostim Reduce Chemo Disruptions in GI Cancer?

A recent analysis assesses whether romiplostim can reduce thrombocytopenia-driven chemotherapy dose reductions, delays, and discontinuations.

Tumor Debulking Fails to Boost Survival in Metastatic CRC

Researchers evaluated whether adding tumor debulking to standard palliative systemic therapy improves survival in patients with multiorgan metastatic colorectal cancer in the ORCHESTRA trial.

Recommended News For You

Short Shrift in Cancer Funding; Bypassing Familiar for Distant; Testing for BRCA.

Don't Call It Cancer; Clues to 'Exceptional' Responses; More Predictions for 2025

According to research, the mineralization of the bone matrix controls the growth of tumor cells.

As compared to proton therapy, proton therapy is very effective in treating esophageal cancer.

Child Death Rates Are Rising in the U. s. ; Water Beads Warning; Cancer Studies Retracted.

FDA OKs Upfront Nivolumab+Chemo for Classic Hodgkin Lymphoma

Potentially Novel Approach for Treating Advanced Colorectal Cancer with KRAS Mutations.

Recommended Articles For You

The Silent Danger of Hematoma: How to Identify and Treat This Potentially Serious Condition 

Cardiotoxicity Beyond Anthracyclines: Redefining Risk in the Cardio-Oncology Era 

Understanding Odontogenic Keratocyst: Symptoms, Causes, and Treatments from Dental Experts 

Interplay of Brown Hair, Follicular Biology, and Hair Growth Inhibitors in Melanoma Pathogenesis 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Patients with resected head and neck cancers may benefit clinically from an investigational personalized vaccine.

2.

Guideline on management of early-stage non-small cell lung cancer released

3.

Pancreatic cancer patients who were prescribed lorazepam for anxiety had poorer survival rates.

4.

Medical debt in collections persists after cancer diagnosis

5.

Diet and Prostate Cancer; TTFields OK'd for NSCLC; Cancer Studies Retracted

1.

Malignant Prolactinoma: Prolactin Surge with Minimal Growth Masks Widespread Metastases

2.

Unraveling the Complexities of Embryonal Carcinoma: A New Hope for Treatment

3.

Understanding Sickle Cell Anemia: Causes, Symptoms, and Treatment Options 

4.

Hemophilia: Pathophysiology, Genetics, and Treatment Advances

5.

Cancer-Keeper Genes: Novel Therapeutic Targets for Disrupting Tumor Maintenance

1.

International Lung Cancer Congress®

2.

Genito-Urinary Oncology Summit 2026

3.

Future NRG Oncology Meeting

4.

ISMB 2026 (Intelligent Systems for Molecular Biology)

5.

Annual International Congress on the Future of Breast Cancer East

1.

Daratumumab, Lenalidomide, and Dexamethasone (DRd) Versus Lenalidomide and Dexamethasone (Rd) in MRD Negativity

2.

Role of Nimotuzumab in Management of Nasopharyngeal Cancer

3.

"Lorlatinib Upfront": A Niche but Powerful Option For ALK+ NSCLC

4.

Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part III

5.

Managing ALK Rearranged Non-Small Cell Lung Cancer with Lorlatinib - Part II

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot